Active Litigations

These are the litigations for which LegalWisdom currently offers free case reviews. Eligibility is always determined by an independent law firm. Reviews for additional litigations open regularly. Leave your email on a case below and we will let you know the moment it opens.

Case reviews open

Depo-Provera and Meningioma

A 2024 study published in The BMJ reported an increased risk of meningioma associated with long-term use of medroxyprogesterone acetate, the active ingredient in Depo-Provera. In December 2025 the FDA approved updated labeling that warns about meningioma. Federal lawsuits have been consolidated in MDL 3140 in the Northern District of Florida. Women who received Depo-Provera injections and were later diagnosed with a meningioma may qualify for a free case review.

Check If I May Qualify

Case reviews opening soon

Talcum Powder and Ovarian Cancer

Lawsuits allege that long term use of talc based powder products contributed to ovarian cancer. This is the largest active mass tort in the United States, with more than 67,000 pending cases in federal court. Case reviews through LegalWisdom are opening soon.

Case reviews opening soon

Chemical Hair Relaxers

Lawsuits allege that long term use of chemical hair relaxers is linked to uterine and ovarian cancer, with more than 11,000 cases pending in federal court. Case reviews through LegalWisdom are opening soon.

Case reviews opening soon

Paragard IUD

Lawsuits allege that the copper Paragard IUD can break during removal, leaving fragments that may require surgical procedures. Bellwether trials in the Paragard litigation were anticipated for early 2026. Case reviews through LegalWisdom are opening soon.

Case reviews opening soon

GLP-1 Weight Loss Medications

Lawsuits allege that manufacturers of GLP-1 medications such as Ozempic, Wegovy, and Mounjaro failed to warn about severe gastrointestinal injuries, including gastroparesis. This is one of the fastest growing litigations in the federal court system. Case reviews through LegalWisdom are opening soon.